PharmaSUG2026PK/PD/ADA and Quantitative Pharmacology
Early Unblinding to Pharmacometrics (PMx) Data: Challenges, Practices, and Benefits
Paper PK-216
Community reference directory
Conference Papers
Find papers in official PHUSE, PharmaSUG, and WUSS proceedings. Search by title or paper number, then narrow the directory by conference, year, or category.
Official links only—files are not hosted by ClinStandards.
Showing 476–500 of 4,481 papers
Open official paper
PharmaSUG2026PK/PD/ADA and Quantitative Pharmacology
Visualizing PK and ADA Data at Scale: A Parameter-Driven SAS Macro for Box Plot Generation
Paper PK-234
PharmaSUG2026PK/PD/ADA and Quantitative Pharmacology
Navigating Early Career Challenges in PK/ADA Statistical Programming
Paper PK-250
PharmaSUG2026PK/PD/ADA and Quantitative Pharmacology
An End-to-End R-Based Pharmacokinetics (PK) Workflow for Regulatory Submission: The INAVO120 Study
Paper PK-272
PharmaSUG2026PK/PD/ADA and Quantitative Pharmacology
SAS and R for Expanding Data for Pharmacometrics Analysis (PMx) Analysis Data Sets
Paper PK-276
PharmaSUG2026PK/PD/ADA and Quantitative Pharmacology
From Chaos to Clarity: A Programmer’s Perspective on Standardizing Population Pharmacokinetic (PopPK) Data for Regulatory Success
Paper PK-282
PharmaSUG2026PK/PD/ADA and Quantitative Pharmacology
Enhancing ADaM PK Datasets to Automate PK TFLs Generation
Paper PK-310
PharmaSUG2026PK/PD/ADA and Quantitative Pharmacology
Two Paths, One PK Journey: The Art of Balancing ADPC and ADNCA
Paper PK-334
PharmaSUG2026PK/PD/ADA and Quantitative Pharmacology
Early Restricted Unblinded PK Data Access (ERUPA): Framework to Accelerate PopPK and ERES Deliverables Through Data-Centric, Firewalled Workflows
Paper PK-361
PharmaSUG2026PK/PD/ADA and Quantitative Pharmacology
A systematic approach for imputing missing dose information in population pharmacokinetic analysis datasets
Paper PK-387
PharmaSUG2026Panel Discussions
ADaM Pet Peeves Part 2: More Things Programmers Do That Make Us Crazy
Paper PN-245
PharmaSUG2026Real-World Data (RWD) and Real-World Evidence (RWE)
Streamlining Workflows in Real-World Evidence Studies with an R-Based Automation Tool
Paper RW-126
PharmaSUG2026Real-World Data (RWD) and Real-World Evidence (RWE)
Corticosteroids in severe COVID-19 across molecular endotypes and vaccination status: an Emulated Target Trial approach to benchmark to and extend upon findings from RECOVERY
Paper RW-186
PharmaSUG2026Real-World Data (RWD) and Real-World Evidence (RWE)
dbLoadTable: A Robust and Efficient Solution for Bulk Data Transfer in Real-World Evidence Analytics
Paper RW-210
PharmaSUG2026Real-World Data (RWD) and Real-World Evidence (RWE)
Real World Data and CDISC – An Evolving Journey
Paper RW-248
PharmaSUG2026Real-World Data (RWD) and Real-World Evidence (RWE)
Embracing Novel Approaches to Automated Causal Inference Framework
Paper RW-253
PharmaSUG2026Real-World Data (RWD) and Real-World Evidence (RWE)
From Automation to Evidence: Governing LLMs and AI Agents in Real-World Outcomes Research
Paper RW-343
PharmaSUG2026Real-World Data (RWD) and Real-World Evidence (RWE)
PSMATCH: Propensity Score Matching of Clinical Trial Data with External Control Arms
Paper RW-367
PharmaSUG2026Real-World Data (RWD) and Real-World Evidence (RWE)
Contrast Effects in Curated Observational Data
Paper RW-379
PharmaSUG2026Real-World Data (RWD) and Real-World Evidence (RWE)
Assessing Quality of Real-World Data Sources
Paper RW-384
PharmaSUG2026Real-World Data (RWD) and Real-World Evidence (RWE)
Biostatistical Foundations 201: Privacy Preserving Patient Linkage Across Real World Data Sources
Paper RW-429
PharmaSUG2026Real-World Data (RWD) and Real-World Evidence (RWE)
Operationalizing Real World Data for External Control Arms: An End to End Framework for Rare Disease and Oncology Trials
Paper RW-435
PharmaSUG2026Study Data Integration & Analysis
Insights and Experience Sharing with Patient-Reported Outcome Data Analysis in FDA’s Submission
Paper SI-109
PharmaSUG2026Study Data Integration & Analysis
A Statistical Programmer’s Guide to Tipping Point Analysis in SAS
Paper SI-227
PharmaSUG2026Study Data Integration & Analysis
From Data to Dossier: Lessons from Cross-Company Regulatory Submissions
Paper SI-293